Immediate Impact
2 from Science/Nature 59 standout
Citing Papers
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
New promises and challenges in the treatment of advanced non-small-cell lung cancer
2024 Standout
Works of Ana B. Oton being referenced
Factors Associated with Adherence to and Treatment Duration of Erlotinib Among Patients with Non-Small Cell Lung Cancer
2017
Neratinib (N) with or Without Temsirolimus (Tem) in Patients (Pts) with Non-Small Cell Lung Cancer (Nsclc) Carrying Her2 Somatic Mutations: an International Randomized Phase Ii Study
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Ana B. Oton | 1052 | 1005 | 409 | 38 | 1.6k | |
| Ana C. Xavier | 1098 | 1032 | 503 | 47 | 1.7k | |
| Heidi H. Gillenwater | 989 | 852 | 384 | 31 | 1.6k | |
| M. Clerici | 1208 | 1328 | 490 | 33 | 2.1k | |
| Patricia Stephenson | 862 | 682 | 370 | 46 | 1.7k | |
| C. Calandri | 911 | 929 | 390 | 25 | 1.5k | |
| Jackie Walling | 863 | 1008 | 652 | 44 | 1.9k | |
| Lina Tang | 632 | 814 | 435 | 73 | 1.5k | |
| David F. Heigener | 994 | 1044 | 640 | 69 | 1.9k | |
| Amelia Insa | 674 | 1061 | 306 | 60 | 1.5k | |
| Xiaolei Zhu | 656 | 816 | 591 | 34 | 2.0k |
All Works
Login with ORCID to disown or claim papers
Loading papers...